PRGO News and Press, Perrigo Company plc From 04/25/24

2024-04-25 07:00:42 ET More on Perrigo Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth CVS Health to cover Perrigo OTC birth control pill Perrigo launches Opill, first OTC birth control pill in U.S. Read the full article on Seeki...

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million PR Newswire Proposed Divestment of Branded Prescription Pharma Business Further Supports Perrigo's Strategic Focus on Consumer Self-Care Total Purchase Consider...

Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024 PR Newswire DUBLIN , April 23, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first qu...

2024-04-17 11:05:00 ET Summary Heartland Advisors is a boutique, independent investment firm in Milwaukee, WI. Our value-focused, actively managed product suite includes distinct U.S. and international investing strategies, which are offered through five mutual funds and four separate...

2024-04-17 10:55:00 ET Summary Heartland Advisors is a boutique, independent investment firm in Milwaukee, WI. Our value-focused, actively managed product suite includes distinct U.S. and international investing strategies, which are offered through five mutual funds and four separate...

Opill and WNBA Team Up for Groundbreaking Partnership PR Newswire --The Two Revolutionary Brands Will Redefine Contraception Accessibility-- GRAND RAPIDS, Mich. and NEW YORK , April 9, 2024 /PRNewswire/ -- Today, Perrigo Company plc, a leading p...

2024-04-09 05:49:33 ET Summary After nearly a decade of struggles, Perrigo is poised to turn the corner under the leadership of a new CEO who is only nine months in the seat. Infant formula woes will be resolved in Q2 and comparisons year over year will start to be favorable in th...

2024-04-08 08:00:07 ET Korinne Wolmeyer from Piper Sandler issued a price target of $39.00 for PRGO on 2024-04-08 07:01:00. The adjusted price target was set to $39.00. At the time of the announcement, PRGO was trading at $31.4. The overall price target consensus is at $...

2024-04-04 15:36:46 ET More on CVS Health, Perrigo, etc. CVS Health: Here Comes The Floor - Inherent Undervaluation Triggers Great Upside Potential Still Undervalued, But Questions About CVS Health's Competitive Advantage Remain (Rating Downgrade) CVS Health: Better ...

2024-03-28 13:49:05 ET More on Invesco S&P 500 Equal Weight ETF: RSP: Equal Weighting The S&P 500 To Minimize Magnificent Seven Exposure Is Not Optimal RSP: I Firmly Believe In An Allocation To Equal-Weight At This Juncture RSP: Happy 2024! Don't Make Decisio...